Clinical description According to the clinical symptoms, glutathione synthetase deficiency can be classified as mild, moderate or severe [19]: Mild glutathione synthetase deficiency These patients show mild hemolytic anemia as their only clinical symptom
Ding C, Saw CB, Timmerman RD
Dihexa is reported to be active at picomolar concentrations in synaptogenesis assaysapproximately 10,00010,000,000-fold more potent than BDNF (brain-derived neurotrophic factor) in some in vitro measures, though this comparison involves different assay conditions and should not be taken as a direct clinical equivalence claim
Schmitt J, Rosumeck S, Thomaschewski G, Sporbeck B, Haufe E, Nast A
The future of peptide therapy Rogan's discussions reflect a moment in peptide history when interest is exploding but research lags behind